Maureen E. Thyne, RPA-C, Weill Cornell Medical College, discusses the impact that ruxolitinib (Jakafi) has had on patients with myelofibrosis.
Maureen E. Thyne, RPA-C
Advertisement
Articles by Maureen E. Thyne, RPA-C
Advertisement
Latest Updated Articles
Maureen E. Thyne Discusses Ruxolitinib's Impact on MyelofibrosisPublished: September 13th 2016 | Updated:
Advertisement
Advertisement
